BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Gloucester Pharmaceuticals, Inc. 

One Broadway, Suite 600

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-621-1561 Fax: 617-577-1209


SEARCH JOBS


Industry
Biotechnology






 Company News
Celgene (CELG) Completes Acquisition of Gloucester Pharmaceuticals, Inc. 1/15/2010 9:19:23 AM    More...
Gloucester Pharmaceuticals, Inc. Presents ISTODAX(R) Data Demonstrating Clinical Benefit in Patients with CTCL Including Blood Involvement at American Society of Hematology Annual Meeting 12/7/2009 10:20:04 AM    More...
Celgene (CELG) (JOBS) to Buy Gloucester Pharmaceuticals, Inc. in Cancer Drug Deal; Celgene to Pay $340 Million in Cash, $300 Million in Milestones 12/7/2009 6:52:58 AM    More...
Gloucester Pharmaceuticals, Inc. Release: ISTODAX(R) Incorporated Into National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology(TM) for the Treatment of Cutaneous T-cell Lymphoma (CTCL) 12/3/2009 12:32:09 PM    More...
Gloucester Pharmaceuticals, Inc. to Present Positive Results from Multiple Studies of ISTODAX(R) at the American Society of Hematology Annual Meeting 11/25/2009 9:15:16 AM    More...
FDA Approves Gloucester Pharmaceuticals, Inc.'s ISTODAX(R) for Patients with Cutaneous T-cell Lymphoma 11/6/2009 7:01:28 AM    More...
FDA Advisory Committee Recommends Gloucester Pharmaceuticals, Inc.'s Romidepsin for Approval for Cutaneous T-cell Lymphoma 9/2/2009 1:53:42 PM    More...
Gloucester Pharmaceuticals, Inc. Gears Up for FDA Panel Vote on Lymphoma Drug 9/2/2009 7:43:29 AM    More...
Gloucester Pharmaceuticals, Inc. Completes $29 Million Financing 8/25/2009 6:56:11 AM    More...
Gloucester Pharmaceuticals, Inc. Announces FDA Advisory Committee Meeting to Discuss Romidepsin New Drug Application 8/17/2009 9:18:14 AM    More...
123456

//-->